The results showed that three genes (TXNIP, CD44, and ENTPD1) were significantly upregulated in peripheral blood from high-risk PBC patients, while the expression of PDGFRB was not statistically different between the two groups (Fig. 8A–D). This evidence concerns the gene ENTPD1 and primary biliary cholangitis.